Athira Pharma, Inc.
ATHA
$0.3848
$0.00481.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -30.65% | -15.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.54% | -38.74% | |||
| Operating Income | 23.54% | 38.74% | |||
| Income Before Tax | 23.81% | 39.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 23.81% | 39.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.81% | 39.06% | |||
| EBIT | 23.54% | 38.74% | |||
| EBITDA | 24.16% | 39.35% | |||
| EPS Basic | 23.91% | 39.58% | |||
| Normalized Basic EPS | 24.42% | 39.27% | |||
| EPS Diluted | 23.91% | 39.58% | |||
| Normalized Diluted EPS | 24.42% | 39.27% | |||
| Average Basic Shares Outstanding | 0.13% | 0.88% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||